Eligibility criteria add to race gap in pancreatic cancer clinical trials

Traditional eligibility criteria differentially exclude Black patients from participating in clinical trials for pancreatic ductal adenocarcinoma (PDAC), according to a study published online March 22 in the Journal of Clinical Oncology.